English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Corresponding author: Amal Satte, Neurophysiology Department Hôpital Militaire d’Instruction Mohammed V Rabat Maroc Tel: +212 664 723 716 Email: satteamal@gmail.com Introduction Epilepsy remains a significant problem of public health in emerging countries. At least 50 million people in the world have epilepsy and approximately 85% of them live in developing countries1,2,3. The high incidence of epilepsy in these countries is often due to parasitic and bacterial infections (such as cysticercosis, toxoplasmosis, hydatid cysts, tuberculosis...), perinatal hypoxia due to poor conditions for home births and maternal diseases, head trauma, toxic agents (including alcohol and drugs), and hereditary factors.4,5 Besides the high frequency of epilepsy, treatment in emerging countries is also a problem. A large percentage of the population with epilepsy is not properly treated6.

Why should modified Atkins diet be encouraged for treating epilepsy in emerging countries?